ABSTRACT Homozygous Watanabe hereditary hyperlipidemic (WHHL) rabbits have a near-complete deficiency of low density lipoprotein (LDL) receptors in liver and other tissues. As a result, these rabbits clear LDL from plasma at an abnormally slow rate. In the current studies we show that WHHL rabbits clear chylomicrons from plasma at a normal rate. Chylomicrons are cleared by a two-step process: (i) hydrolysis of triglycerides in extrahepatic tissues to yield cholesteryl ester-rich remnant particles and (ii) rapid uptake of the remnants by the liver. Normal and WHHL rabbits were given intravenous injections of rat chylomicrons labeled either in the lipid portion with [3H]cholesterol and ['4C]palmitate or in the protein portion with ['5I]iodine. All radiolabeled components were removed from plasma at comparable rates in normal and WHHL rabbits. Comparable amounts of radioactivity accumulated in livers of animals from both genotypes. In vitro assays showed that liver membranes from WHHL rabbits were markedly deficient in the binding of'I-labeled chylomicron remnants as well as 125I-labeled LDL, implying that chylomicron remnants can bind to the hepatic LDL receptor. We conclude that the rabbit liver normally has at least two genetically distinct lipoprotein uptake mechanisms, both ofwhich recognize chylomicron remnants: (i) the LDL receptor and (ii) a specific chylomicron remnant uptake mechanism that is not measured adequately by current in vitro membrane binding assays. WHHL rabbits possess a normal chylomicron remnant uptake mechanism that allows them to clear chylomicrons from plasma at a rapid rate despite their genetic deficiency of LDL receptors.
Receptors in the liver play a major role in the removal of lipoproteins from blood. Livers of rabbits, dogs, pigs, and rats express receptors that are similar to the low density lipoprotein (LDL) receptors originally described in extrahepatic cells (for review, see ref. 1). These receptors bind lipoproteins containing apoprotein B (apo-B) or apoprotein E (apo-E), including LDL, ,p3very low density lipoprotein , and a cholesterol-induced high density lipoprotein containing apo-E as its predominant protein (apo-E-HDLc). These hepatic LDL receptors are subject to metabolic regulation and are expressed in variable amounts under differing conditions. For example, they are suppressed by cholesterol feeding (2, 3) and enhanced when animals are given bile acid binding resins (3) (4) (5) , cholesterol synthesis inhibitors (4) , or 17a-ethinyl estradiol (6) .
In addition to the lipoproteins listed above, the hepatic LDL receptor is able to bind chylomicron remnants that are formed during the two-step pathway for chylomicron catabolism (1, 7) .
This pathway begins when dietary cholesterol and triglyceride are incorporated into chylomicrons. Within extrahepatic capillaries, the chylomicrons are digested by lipoprotein lipase which liberates a large fraction ofthe triglycerides, reducing the size of the chylomicron and forming a remnant particle. The remnant-which retains its cholesteryl ester-dissociates from the endothelium and reenters the circulation whereupon it is rapidly cleared by the liver, apparently by binding to a receptor.
Although chylomicron remnants can bind to the LDL receptor, clinical observations suggest that remnants can also enter the liver by another pathway distinct from the LDL receptor (8) . This conclusion is based on findings in patients with homozygous familial hypercholesterolemia who have a genetic deficiency of LDL receptors. As a result of this deficiency, LDL is degraded slowly and it accumulates to massive levels in plasma. Yet chylomicron remnants do not accumulate in plasma of these individuals, suggesting that remnants can be removed normally from the circulation despite a deficiency of LDL receptors (7, 8) .
The uptake of chylomicron remnants by liver is likely to be mediated by a binding site that recognizes one or more of the protein components ofthe remnant, either apo-E (9-11) or apo-B48 (11), a unique form ofapo-B that is present in chylomicrons but not in LDL (12, 13) . Using in vitro membrane binding assays, Mahley and co-workers have shown that the liver of dog, swine, and man contains a binding site that recognizes apo-E but not apo-B, in addition to the LDL receptor, which recognizes both apo-B and apo-E (3, 5) . Like the LDL receptor, this apo-E binding site is inhibited by EDTA. In rats, Cooper et aL have described an EDTA-resistant binding site that also seems specific for apo-E (14). It has not yet been directly shown that the apo-E binding site as measured by these in vitro assays is responsible for the in vivo uptake of chylomicron remnants.
A new way to study the chylomicron remnant receptor has become available as a result of the discovery of the Watanabe heritable hyperlipidemic (WHHL) rabbit (15) . Homozygous WHHL rabbits have a deficiency of LDL receptors, analogous to that of human homozygous familial hypercholesterolemia (16, 17) . As in the human disease, LDL is cleared slowly from the circulation of WHHL rabbits and accumulates to massive levels in plasma (18) . These rabbits have a near-complete deficiency of LDL receptors in liver as revealed by membrane Abbreviations: apo-B, apoprotein B; apo-E, apoprotein E; apo-E-HDLC, a cholesterol-induced lipoprotein containing apo-E as its predominant protein; LDL, low density lipoprotein; HDL, high density lipoprotein; 1-VLDL, (3-migrating very low density lipoprotein; WHHL, Watanabe heritable hyperlipidemic.
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binding studies (17) or by studies of LDL uptake in isolated hepatocytes (19) . The current studies were designed to determine whether the WHHL rabbit is able to clear chylomicron remnants rapidly from the circulation. To prepare "25I-labeled chylomicron ('25I-chylomicron) remnants, we radiolabeled rat chylomicrons (21) and injected them into the femoral veins of functionally eviscerated rats (20) . The rats were bled 30 min later. The serum was adjusted to a density (p) of 1.019 g/ml by addition of D20 in 0.15 M NaCl, layered beneath Krebs-Henseleit buffer, and subjected to ultracentrifugation for 108 X gv min. The '25I-chylomicron remnants (top fraction) were obtained by tube-slicing. Ofthe 12 radioactivity in the remnants, 98% was precipitated by trichloroacetic acid and 13% was extracted into chloroform/methanol. 125I-Labeled canine apo-E-HDLc (3) was kindly provided by'T. L. Innerarity and R. W. Mahley. Rabbit P-VLDL, LDL, and HDL3 were prepared as described (2) .
METHODS
In the venous catheter, followed by 1 ml of "25I-labeled human serum albumin (2.4 uCi; 1 Ci = 3.7 X 1010 becquerels). Sam- ples of blood (3 ml) were obtained from the femoral arterial cannula as indicated. The blood was mixed with 0.3 mg of disodium EDTA and immediately placed on ice. One-milliliter samples of blood plasma, obtained by centrifugation at 7,000 x g., min. were layered beneath Krebs-Henseleit buffer and subjected to ultracentrifugation at plasma density for 108 X gav min at 12°C. Supernatant and infranatant fractions were recovered after tube-slicing, extracted, and subjected to TLC (22 (1:1) . Bleeding from the cut liver edge was arrested with Gelfoam (Upjohn). After the 60-min sample was taken, the portal vein was cannulated, the vena cava was incised, and the liver was perfused with 100 ml ofice-cold 0.15 M NaCl. The liver was weighed, and lipids were extracted from pieces taken from each lobe, as above. Lipids were also extracted from other tissues, separated, and quantified as above.
Membrane Binding of "25I-Labeled Lipoproteins ('25I-Lipoproteins). Rabbit liver membranes (fraction sedimenting between 8,000 and 100,000 x g) were prepared as described (17) . The standard binding assay (17) (Fig. 1A) . In WHHL rabbits, the rates of removal of the two labeled lipids were also comparable but more rapid than in the normals, with an initial half-time of8 min (Fig. 1B) Normal and WHHL rabbits cleared rat '"I-chylomicrons from the plasma at comparable rates (Fig. 2) . The initial halftime for the disappearance of 1"I radioactivity from whole plasma was 20-25 min in both strains. To compare the hepatic uptake of '"I-chylomicrons, the animals were killed after 15 min, the livers were perfused to remove excess blood, and samples of tissue were taken for measurement of "2I radioactivity (2) . In two WHHL rabbits, values of 15% and 21% of injected radioactivity were found in the liver. In two normal rabbits, the corresponding values were 13% and 17%. During this interval about 30% of the injected "2I radioactivity had disappeared from plasma in both species (Fig. 2) . Thus, about 50% of the 125I radioactivity that disappeared from the plasma was found in the liver. Fig. 3A shows that membranes from the livers ofnormal rab- from normal rabbits (Fig. 4A) . Binding was inhibited by EDTA.
Unlabeled apo-E-HDLc reduced the binding to a greater extent than EDTA, suggesting that the 125I-apo-E-HDLc binds both to EDTA-sensitive and to EDTA-resistant sites. WHHL rabbits had some ability to bind the apo-E-HDL,, and there was definite inhibition by EDTA (Fig. 4B) . However, the amount of EDTA-sensitive binding was reduced by 80% when compared with the normal (Fig. 4C) . § The amount of EDTA-resistant binding was similar in the two strains. from rabbit intestinal lymph, injected into two normal rabbits, were removed from the blood at rates similar to those observed with double-labeled rat lymph chylomicrons. In samples of normal liver taken 30 min after injection, 67% and 70% of the [3H]cholesteryl esters removed from plasma were found in the liver (data not shown).
DISCUSSION
In WHHL rabbits injected with double-labeled rat chylomicrons, a substantial fraction (40%) of the [3H]cholesteryl esters was found in the plasma fraction of p >1.006 g/ml after 60 min, as compared to 15% in normal rabbits. This may be attributable to the high activity of cholesteryl ester transfer protein present in rabbit plasma (25) and the large pool of cholesteryl ester in the LDL fraction of the WHHL rabbit (18) .
It is noteworthy that liver membranes from WHHL rabbits bound small amounts of chylomicron remnants to a site that was susceptible to competition by LDL and f3-VLDL but was not inhibited by EDTA, which blocks binding to the LDL receptor. This EDTA-resistant binding (17) is difficult to evaluate because it was apparently of much lower affinity than binding to the LDL receptor-i.e., it did not show saturation within the concentration range of chylomicron remnants used in the current studies. In the rat, Cooper et al. have shown that hepatic binding of chylomicron remnants to an EDTA-resistant site is much higher at 370C than at 40C (14) . We have not evaluated the binding ofchylomicron remnants to rabbit liver membranes at 37TC. In contrast to the EDTA-sensitive site that is specific for lipoproteins containing apo-B and apo-E, binding of '"I-lipoproteins to the EDTA-resistant site at 0C was competitively inhibited by all lipoproteins tested, including HDL3 and methylated LDL. The 8,000-100,000 x g-fraction of liver membranes was used in the current studies, but similar results were obtained when the whole homogenate or the 8,000 X g-pellet was used at 0C (data not shown). Because there are no specific inhibitors of this EDTA-resistant binding and because there are no mutants in which this site is absent, it is not yet possible to determine whether this EDTA-resistant binding site functions as a remnant receptor in vivo.
It has been suggested that apo-E is the protein component of chylomicron remnants that is recognized by the remnant receptor (9-11). In normal rabbits this point is difficult to study because chylomicron remnants bind to LDL receptors as well as to remnant receptors. Binding of remnants to LDL receptors is mediated by the content of apo-E, which binds with high affinity to LDL receptors (1, 3) . Whether apo-E also mediates binding to the rabbit chylomicron remnant receptor is not known. In the current studies, we found that the binding of "2I-labeled canine apo-E-HDLc to WHHL liver membranes was markedly decreased, consistent with the reduction in LDL receptors. § However, both normal and WHHL membranes exhibited similar-though small-amounts of EDTA-resistant binding of apo-E-HDL,. If the EDTA-resistant binding represents the chylomicron remnant receptor, these data would indicate that the remnant receptor recognizes apo-E. It should also be noted that the apo-B of chylomicrons differs from that of VLDL and LDL not only in rats (13) and humans (12) but also in rabbits (unpublished observations). It is possible that the chylomicron apo-B (so-called B-48) mediates binding to the remnant receptor.
Mahley and co-workers have shown that canine and human liver contain a specific apo-E binding site that is distinct from the LDL receptor (which binds both apo-B and apo-E) (3, 5) . In their studies, the apo-E specific site was inhibited by EDTA-i. e., it was EDTA-sensitive. In the current studies, we sensitive apo-E binding sites, suggesting that rabbits may not produce an EDTA-sensitive receptor other than the LDL receptor. § As discussed above, if there is a separate apo-E receptor in these animals, it is possibly EDTA-resistant.
The current findings in WHHL rabbits have relevance to homozygous familial hypercholesterolemia, a human disease in which the LDL receptor is also genetically absent. Despite the absence of LDL receptors and the resultant massive accumulation of plasma LDL, these individuals do not appear to accumulate chylomicron remnants (7, 8) . Thus, it seems that humans-like rabbits-must have a chylomicron remnant uptake mechanism that differs genetically from the LDL receptor and remains intact when the LDL receptor is genetically absent. Sandra Miranda, Richard Gibson, and James Ingram provided excellent technical assistance. This research was supported by grants from the National Institutes of Health (HL 20948 and HL 14237) and the Moss Heart Foundation. C.A.H. is the recipient of a California Heart Association Fellowship.
